Authors:
Kumura, T
Hino, M
Yamane, T
Ohta, K
Nakao, T
Wakasa, K
Tatsumi, N
Citation: T. Kumura et al., Triple-negative (CD3(-)/CD4(-)/CD8(-)) adult T cell leukemia/lymphoma, histologically presenting as CD30 (Ki-1)-positive anaplastic large cell lymphoma with clonal Epstein-Barr virus genome, LEUKEMIA, 15(6), 2001, pp. 994-995
Authors:
Takubo, T
Fujino, H
Hino, M
Yamane, T
Ohta, K
Koh, KR
Kumura, T
Hashimoto, S
Nakao, T
Nakamae, H
Aoyama, Y
Nishiki, S
Kinoshita, Y
Kamitani, T
Tatsumi, N
Hojo, S
Fujita, J
Citation: T. Takubo et al., Expression of KL-6 antigen on leukemia cells of a patient with chronic myelocytic leukemia in blastic phase, HAEMATOLOGI, 31(2), 2001, pp. 173-176
Authors:
Takubo, T
Kumura, T
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Elevation of serum procalcitonin level in a patient with chronic myelocytic leukemia, HAEMATOLOGI, 31(2), 2001, pp. 177-179
Authors:
Takubo, T
Kumura, T
Nakao, T
Nakamae, H
Aoyama, Y
Kinoshita, Y
Koh, KR
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Expression of human interleukin-18 antigen in leukemia cells of a patient with acute mixed lineage leukemia, HAEMATOLOGI, 31(1), 2001, pp. 69-71
Citation: T. Kumura et al., Convergence performance of adaptive lattice filters with nonlinear parameter updates, IEE P-VIS I, 147(3), 2000, pp. 238-246
Authors:
Takubo, T
Ohkura, H
Kumura, T
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Lymphoma in Castleman's disease, acute lymphocytic leukemia, adult T-cell leukemia and cutaneous T-cell lymphoma accompanied with high serum soluble Fas ligand levels, HAEMATOLOGI, 30(1), 2000, pp. 23-26
Authors:
Kumura, T
Hino, M
Yamane, T
Tominaga, K
Tatsumi, N
Citation: T. Kumura et al., DX-9065a, a specific factor Xa inhibitor, as a universal anticoagulant forblood collection tubes, CLIN CHIM A, 294(1-2), 2000, pp. 27-35
Authors:
Takubo, T
Kumura, T
Nakao, T
Nakamae, H
Aoyama, Y
Nishiki, S
Kinoshita, Y
Koh, KR
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Comparative study on complete remission rate and overall survival in threegroups classified based on the serum interleukin-18 level in non-Hodgkin'slymphoma patients, ACT HAEMAT, 104(4), 2000, pp. 220-222
Authors:
Takubo, T
Kumura, T
Nakao, T
Nakamae, H
Aoyama, Y
Nishiki, S
Kinoshita, Y
Koh, KR
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Clinical usefulness of combined measurements of serum soluble transferrin receptor levels and serum interleukin-18 levels at determination of serum KL-6 levels in haematologic malignancies, ACT HAEMAT, 104(2-3), 2000, pp. 141-143
Authors:
Takubo, T
Okura, H
Kumura, T
Nishiki, S
Kinoshita, Y
Koh, KR
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Human IL-18 bioactivity in hematological malignancies with highly elevatedserum IL-18 levels, ACT HAEMAT, 103(3), 2000, pp. 162-164
Authors:
Takubo, T
Kumura, T
Nishiki, S
Kinoshita, Y
Koh, KR
Ohta, K
Yamane, T
Hino, M
Kamitani, T
Tatsumi, N
Citation: T. Takubo et al., Clinical significance of simultaneous determination of serum soluble transferrin receptor, soluble fas, soluble fas ligand, hepatocyte growth factor and interleukin 18 levels in a patient with hemophagocytic syndrome, ACT HAEMAT, 103(3), 2000, pp. 165-167